PGY1 pharmacy residency
Program purpose
The PGY1 residency program builds upon Doctor of Pharmacy (Pharm.D.) education and outcomes to develop pharmacist practitioners with knowledge, skills, and abilities as defined in the educational competency areas, goals, and objectives. Residents who successfully complete a PGY1 residency program will be skilled in diverse patient care, practice management, leadership, and education, and be prepared to provide patient care, seek board certification in pharmacotherapy (i.e., BCPS), and pursue advanced education and training opportunities including postgraduate year two (PGY2) residencies.
Program description
The PGY1 Pharmacy Residency is designed to accelerate the resident’s growth beyond entry-level professional competence in pharmacy services and to further develop leadership skills. The residency offers an environment for accelerating growth beyond entry-level professional competence through supervised practice under the guidance of model practitioners. Residents will be held responsible and accountable for acquiring outcome-based competencies for the managing and improving the medication-use process, providing evidence-based, patient-centered medication therapy management with interdisciplinary teams, exercising leadership and practice management, demonstrating project management skills, providing medication and practice-related education/training and utilizing medical informatics. The PGY1 Pharmacy Residency graduates will possess competencies that enable success as general clinicians. Graduates are prepared to enter general clinical practice, PGY2 residency or a fellowship program.
Program structure
The program director will develop an experiential plan at the beginning of the program for each resident. The experiential component shall consist of the following required, elective, and selective learning experiences (see image below). The needs of the resident and the attributes of the residency program will be utilized in the development of the plan. Additional electives may be available based on the resident’s interests.
Please feel free to contact either Grace Akinyemi, PharmD or Jen Siebenberg, PharmD if you have questions about our program.
-
Staffing component
Staffing commitment shall be a total of 274 hours during the residency year. Currently, PGY1 residents are scheduled to staff every 4th weekend in Central Pharmacy Operations. Additional shifts may be needed to meet the 274 hour total.
-
Education opportunities
A teaching certificate is offered in conjunction with Texas Tech University Health Sciences Center (TTUHSC) School of Pharmacy. Residents will also have the opportunity to lead pharmacy student topic discussions, mentor pharmacy interns, participate in the weekly pharmacy lunch-and-learn educational series, complete a medication use evaluation (MUE), and deliver a continuing education presentation.
Each resident is assigned to a Pharmacy Scholarly Oversight Committee to provide support and mentorship for the longitudinal research project. This committee will allow the resident to create and maintain realistic deadlines and goals to complete a successful project and develop a manuscript for publication submission.
PGY1 residents will have the opportunity to attend the ASHP Midyear Clinical Meeting and present their research at the Pediatric Pharmacy Association (PPA) Annual Meeting.
-
Benefits
The PGY1 annual salary is $52,000. Travel support is provided for the ASHP Midyear Clinical Meeting and the PPA Annual Meeting. A dedicated workspace with desktop computer, phone, and laptop are also provided.
The Children’s Health benefits program includes medical, dental, vision, prescription, fertility, disability, and life insurance plans. Employee retirement savings plans, paid time off, and dependent care savings plans are also available.
-
Program requirements/application process
Applicants must be graduates or candidates for graduation of an American Council on Pharmaceutical Education (ACPE) accredited degree program (or one in the process of pursuing accreditation) or have a Foreign Pharmacy Graduate Equivalency Committee (FPGEC) certificate from the National Association of Boards of Pharmacy (NABP).
Applicants must also be eligible for licensure in the state of Texas. Each resident is required to become licensed in the state of Texas within 90 days of the residency start year. The Children’s Medical Center Pharmacy Practice Residency Program (PGY1) uses the Pharmacy Online Residency Centralized Application Service (PhORCAS) for all required materials. Candidate selection is based on evaluation of documents submitted in PhORCAS and phone/on-site interview(s).
A pre-employment screening process will follow the receipt of your application and may include a criminal background check, verification of prior employment, drug screen, physical, and evidence of authorization to work in the United States.
Applicants must submit the following documents via PhORCAS by January 2, 2025:
- One-page letter of intent
- Curriculum vitae
- Three (3) letters of recommendation
- Official transcript from pharmacy school
Additionally, all applicants must complete a Pharmacy Resident job application at jobsearch.childrens.com.
Interviews for PGY1 residency candidates will be conducted in February 2025.
PhORCAS Program Name: Children’s Medical Center Dallas
-
Additional program documents